학술논문

TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model
Document Type
Article
Source
In: Frontiers in Immunology. (Frontiers in Immunology, 2024, 15)
Subject
Language
English
ISSN
16643224